Array BioPharma Revenue and Competitors

Boulder, CO USA

Location

$121.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Array BioPharma's estimated annual revenue is currently $195M per year.(i)
  • Array BioPharma received $6.2M in venture funding in December 2017.
  • Array BioPharma's estimated revenue per employee is $1,598,361
  • Array BioPharma's total funding is $121.4M.
  • Array BioPharma's current valuation is $10.3M. (July 2019)

Employee Data

  • Array BioPharma has 122 Employees.(i)
  • Array BioPharma grew their employee count by 0% last year.

Array BioPharma's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
COOReveal Email/Phone
3
CFOReveal Email/Phone
4
CEOReveal Email/Phone
5
VP, Global Market AnalyticsReveal Email/Phone
6
SVP HRReveal Email/Phone
7
Associate Director, Drug Product ManufacturingReveal Email/Phone
8
Chief Scientific OfficerReveal Email/Phone
9
Sr. Director, Clinical Research ScientistReveal Email/Phone
10
Associate Director Clinical PharmacologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$10.3M516%N/AN/A
#3
$4.4M22-8%N/AN/A
#4
$195M1220%$121.4MN/A
#5
$4.8M24-20%N/AN/A
#6
$6.8M34-19%N/AN/A
#7
$4.8M240%N/AN/A
#8
$4M40-11%$138MN/A
#9
$4.8M24-14%N/AN/A
#10
$69.5M346-6%N/AN/A
Add Company

What Is Array BioPharma?

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.

keywords:Biotechnology,Cleantech,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals,Wind Power

$121.4M

Total Funding

122

Number of Employees

$195M

Revenue (est)

0%

Employee Growth %

$10.3M

Valuation

N/A

Accelerator

Array BioPharma News

2022-04-20 - Non-Receptor Tyrosine Protein Kinase TYK2 Market Size ...

Array BioPharma Inc, Pfizer Inc, Portola Pharmaceuticals Inc, Bristol-Myers Squibb Company, Nimbus Therapeutics LLC, Sareum Holdings Plc,...

2022-04-17 - Non-Receptor Tyrosine Protein Kinase TYK2 Market Size And ...

Array BioPharma Inc, Pfizer Inc, Portola Pharmaceuticals Inc, Bristol-Myers Squibb Company, Nimbus Therapeutics LLC, Sareum Holdings Plc,...

2022-03-30 - Testing for High-Risk Human Papillomavirus in Lower Genital ...

Consulting or Advisory Role: Agenus, Akeso Biopharma, Amgen, Aravive, AstraZeneca ... Janssen (Inst), Array BioPharma (Inst), Tesaro (Inst),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30M12247%N/A
#2
$3.9M12354%$271.7M
#3
$22.5M125-7%N/A
#4
$15M1258%N/A
#5
$25.6M125-6%N/A

Array BioPharma Funding

DateAmountRoundLead InvestorsReference
2002-02-14$30.0MPublic OfferingArticle
2008-05-06$80.0MUndisclosedDeerfield ManagementArticle
2008-12-24$40.0MUndisclosedDeerfield ManagementArticle
2009-05-20$40.0MUndisclosedDeerfield ManagementArticle
2009-09-21$25.0MUndisclosedPiper JaffrayArticle
2012-11-12$65.7MUndisclosedJefferies & Company Inc, JP Morgan Securities LLCArticle
2013-06-05$100.0MUndisclosedGoldman Sachs & Co, J.P Morgan Securities LLCArticle
2013-06-10$17.2MUndisclosedGoldman Sachs & Co, JP Morgan Securities LLCArticle
2016-09-20$1.4MUndisclosedRedmile GroupArticle
2016-10-04$132.2MUndisclosedMultipleArticle
2017-09-15$258.7MUndisclosedJ.P. Morgan Securities LLCArticle
2017-12-05$6.2MUndisclosedArticle